September 13, 2018
Via: ForbesWhile China has prospered in a variety of technologies over the last decade, one area where growth has been slow has been in innovative drug R&D. This is not surprising. Going from an idea to a marketed product can take […]
October 13, 2016
Via: ForbesLast week, John Carroll of Endpoint News sounded an alarm that the productivity of the biopharmaceutical industry is waning since the FDA has only approved 17 drugs in 2016: But even with a 4th-quarter burst of approvals, it will be […]
March 28, 2024
April 19, 2024